Medicare Part D plans cover popular obesity drugs if they are used for an additional medically accepted purpose as approved ...

The government-funded insurance plan will now pay for the drug for patients with obstructive sleep apnea, a condition that ...

Lilly is considering expanding the availability of lower-priced vials of its blockbuster obesity drug Zepbound ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.